scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/S0958-1669(97)80041-9 |
P698 | PubMed publication ID | 9353234 |
P2093 | author name string | Davis HL | |
P2860 | cites work | DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations | Q24563751 |
CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma | Q24568172 | ||
Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization | Q24599495 | ||
DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state | Q24607288 | ||
Gene vaccination with naked plasmid DNA: mechanism of CTL priming | Q24676957 | ||
DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans | Q34209003 | ||
Protection against mycoplasma infection using expression-library immunization | Q34296157 | ||
CpG motifs in bacterial DNA trigger direct B-cell activation | Q34307394 | ||
Immunostimulatory DNA sequences necessary for effective intradermal gene immunization | Q34384185 | ||
Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses | Q35793550 | ||
Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery | Q35868177 | ||
Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. | Q35874803 | ||
Foreign (M13) DNA ingested by mice reaches peripheral leukocytes, spleen, and liver via the intestinal wall mucosa and can be covalently linked to mouse DNA. | Q35966987 | ||
Protection against Mycoplasma pulmonis infection by genetic vaccination | Q36688812 | ||
ELI's coming: expression library immunization and vaccine antigen discovery | Q36809916 | ||
Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells | Q37411183 | ||
DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines | Q37495259 | ||
Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors | Q37513598 | ||
A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA | Q37643556 | ||
Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. | Q40047174 | ||
Particle-mediated nucleic acid immunization | Q41039359 | ||
Genetic immunization | Q41057821 | ||
Immune response to neonatal genetic immunization | Q41127211 | ||
Immune response of neonates elicited by somatic transgene vaccination with naked DNA. | Q41517980 | ||
Genetic immunization is a simple method for eliciting an immune response | Q43857336 | ||
Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells | Q44401631 | ||
Direct gene transfer into mouse muscle in vivo | Q44656494 | ||
Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells | Q45206267 | ||
Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen | Q45764135 | ||
Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. | Q45776437 | ||
Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: implications for a clinically relevant tumor vaccine | Q45878939 | ||
Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA. | Q45881597 | ||
DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. | Q52047718 | ||
Novel pathways of antigen presentation for the maintenance of memory. | Q52100646 | ||
Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. | Q52845358 | ||
Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic Cells | Q56338635 | ||
Protection against papillomavirus with a polynucleotide vaccine | Q70916613 | ||
DNA-based immunization by in vivo transfection of dendritic cells | Q71607054 | ||
DNA vaccines | Q72989814 | ||
P433 | issue | 5 | |
P921 | main subject | immunization | Q1415366 |
P304 | page(s) | 635-646 | |
P577 | publication date | 1997-10-01 | |
P1433 | published in | Current Opinion in Biotechnology | Q15763085 |
P1476 | title | Plasmid DNA expression systems for the purpose of immunization | |
P478 | volume | 8 |
Q30651292 | A DNA vaccine encoding a peptide mimic of Streptococcus pneumoniae serotype 4 capsular polysaccharide induces specific anti-carbohydrate antibodies in Balb/c mice |
Q42237778 | A novel small animal model to study the replication of simian foamy virus in vivo |
Q35224063 | Adjuvant effects of L. acidophilus LW1 on immune responses to the foot-and-mouth disease virus DNA vaccine in mice |
Q33776141 | B-cell malignancies as a model for cancer vaccines: from prototype protein to next generation genetic chemokine fusions |
Q45887167 | Biochemical recovery and purification of gene therapy vectors |
Q43855252 | Co-expression of S. Typhi GroEL and IL-22 gene augments immune responses against Salmonella infection |
Q37348901 | Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization |
Q51588197 | Comparison and critical analysis of robotized technology for monoclonal antibody high-throughput production. |
Q50104824 | Construction and evaluation of a eukaryotic expression plasmid for stable delivery using attenuated Salmonella |
Q43890146 | CpG DNA and LPS induce distinct patterns of activation in human monocytes |
Q38081358 | DNA immunization as an efficient strategy for vaccination |
Q33855482 | DNA immunization to prevent autoimmune diabetes |
Q24806169 | DNA vaccines: improving expression of antigens |
Q40016750 | Gene gun-supported DNA immunisation of chicken for straightforward production of poxvirus-specific IgY antibodies. |
Q40900712 | Generation of high-affinity rabbit polyclonal antibodies to the murine urokinase receptor using DNA immunization |
Q33874465 | Granulocyte-macrophage colony-stimulating factor priming plus papillomavirus E6 DNA vaccination: effects on papilloma formation and regression in the cottontail rabbit papillomavirus--rabbit model |
Q34103313 | Helicobacter pylori vaccine strategies--triggering a gut reaction |
Q43767864 | Immune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus |
Q42181972 | Immunogenicity of a bovine herpesvirus 1 glycoprotein D DNA vaccine complexed with bovine neutrophil beta-defensin 3 |
Q33646629 | Main features of DNA-based immunization vectors |
Q73550937 | Production of polyclonal and monoclonal antibodies against CD54 molecules by intrasplenic immunization of plasmid DNA encoding CD54 protein |
Q33731344 | Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines |
Q45456530 | Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation |
Q41462618 | Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen |
Q40390503 | Rapid-response vaccines--does DNA offer a solution? |
Q77974427 | Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines |
Q34808864 | The application of nucleic acid vaccines in veterinary medicine. |
Q36899352 | The role of high-resolution imaging in the evaluation of nanosystems for bioactive encapsulation and targeted nanotherapy |